• Contact
  • EPAD Academy
Top Bar Menu
TwitterFacebookYouTube
Search...
EPADEPAD
EPAD
European Prevention of Alzheimer's Dementia Consortium
  • Home
  • About
    • Welcome to EPAD
    • Project Objectives
    • Project Structure
    • EPAD Partners
    • Coordination & Management
    • EPAD Q&A
  • Our research
    • Participation in EPAD
      • Participation in EPAD Cohort
      • EPAD Study Visits
      • Trial Locations
      • Participation FAQs
    • The Participant’s Experience
      • The Research Participant Panel
      • EPAD Stories
    • The EPAD platform
      • The EPAD Platform
      • EPAD Benefits
      • Clinical Candidate Selection
      • EPAD FAQs
      • Research Resources
  • Open Access Data
    • Overview
    • Access
    • Data
    • MRI Images
  • Sample Access
  • News & Publications
    • Latest News
    • Newsletters
    • Publications
    • Videos
Menu back  

EPAD Academy has officially started its first activity

2018-01-16EPAD Academy, News

The European Prevention of Alzheimer’s Dementia (EPAD) project launched in 2017 its EPAD Academy that is aiming to efficiently leverage EPAD resources to foster and develop academic research capacity and output in Alzheimer’s disease (AD) across Europe for maximum global impact.

On January 16, the EPAD Academy held its first activity that is to propose online training/webinars by world-class senior researchers on current topics in AD research for young researchers (EPAD Fellows). The first webinar, out of 14 scheduled for 2018, titled “The Dementia Concept after 2020: Research to change Practice, Public Perception and Politicians’ Perspectives” was held by EPAD co-coordinator, Prof Craig Ritchie.

“In this opening presentation – the fundamentals of EPAD are presented with specific reference to the driving societal, political and scientific factors. I hope EPAD fellows will become aware of the opportunities that will exist to them to help shape research policy, prevention and care in the near future”, commented Prof Craig Ritchie.

 

It has been discussed what is the utility of the current disease definitions – do they help or hinder scientific development, and what role does the public, science, the media, politicians and clinicians have in framing discussions and mapping out research direction and public policies on identification, risk management, funding and care. The EPAD Fellows took the opportunity to discuss about the broad context of EPAD in which their own work plays a fundamental part.

In order to promote young researchers´ involvement, the webinar was held exclusively for EPAD fellows. Nevertheless, the presentation has been recorded. If you are curious and interested to sit in on Craig’s webinar, the recording is available on the EPAD You Tube channel.

 

 

Share this post
FacebookTwitterLinkedInGoogle+
Related posts
Analysis of multiple steroids in saliva in the EPAD study
2023-03-02
Hormone Replacement Therapy could ward off Alzheimer’s among at-risk women
2023-01-16
Associations between Mediterranean diet and cognition in the pan-European EPAD LCS
2022-12-09
Bruno Steinkraus
Interview with Dr. Bruno Steinkraus, Chief Scientific Officer at Hummingbird Diagnostics GmbH
2022-11-25
New paper defining and discussing the substantial assets of the EPAD project is out!
2022-11-23
New paper using the EPAD data for an analysis of sleep quality and efficiency
2022-11-03
Latest Academy News
  • Two EPAD Fellows successfully defended their PhD thesis
    2020-04-20
  • David Hague Early Career Investigator of the Year Award 2020
    2019-06-07
  • 9th Call for the 2020 European Young Researchers’ Award is now open
    2019-05-23
  • Interview with Sammy Danso
    2019-01-24
  • Interview with the fellows: Lisa Vermunt and Delia Gheorghe
    2019-01-15
What’s new

The EPAD Academy programme for short-term exchanges is ready to go. EASP is a short-term exchange programme, interdisciplinary and rotational, between the EPAD Consortium Partners, established and supported by the EPAD Academy. Interested? Write to us at academy@ep-ad.org.

Open vacancies

Alzheimer Europe is looking to fill two Luxembourg-based positions! For more info check their website.

Twitter
Twitter
EPAD
EPAD
@IMI_EPAD

📢@imi_epnd has launched its Cohort Catalogue, a central, open & accessible repository for researchers to discover studies & search metadata. Currently 67 research cohorts from 17 countries across Europe including @IMI_EPAD-VUmc participants ⬇️ eurekalert.org/news-releases/… twitter.com/imi_epnd/statu…

reply retweet favorite
9:56 am · 2023-03-14
Twitter
EPAD
EPAD
@IMI_EPAD

NEW paper published in @MetabolitesMDPI using LC-MS/MS method to determine salivary steroids using @IMI_EPAD samples. Congratulations @GregorySarah @zinghomer @guider50 @scottgdenham👏 @EdMassSpecCore @IMI2_NEURONET @IHIEurope #mdpimetabolites mdpi.com/2133518

reply retweet favorite
12:55 pm · 2023-03-02
Twitter
EPAD
EPAD
@IMI_EPAD

"There is a growing consensus that individual research results that are potentially relevant should be reported to research participants” & “Our work was positively received by the EPAD partners, and formed the basis for the set-up & the conduct of the study,” said Eline Bunnik

reply retweet favorite
10:32 am · 2023-01-31
Twitter
EPAD
EPAD
@IMI_EPAD

Have a look on the @IHIEurope newsletter including a spotlight on IMI results from projects on diabetes @HypoResolve and #Alzheimer’s disease @IMI_EPAD @IMI_AMYPAD ⬇️ Read it: bit.ly/3jeaxdM twitter.com/IHIEurope/stat…

reply retweet favorite
10:30 am · 2023-01-31
Twitter
EPAD
EPAD
@IMI_EPAD

17 centres have contributed to the @IMI_AMYPAD Prognostic Study across 11 Parent Cohorts including @IMI_EPAD. Have a look on the latest AMYPAD paper published in @FrontNeurol ⬇️ twitter.com/IMI_AMYPAD/sta…

reply retweet favorite
8:19 am · 2023-01-30
Copyright © 2015-2021 EPAD | Created by CMAST and Aridhia
  • Acronyms
  • Legal Notice
  • Privacy Policy
Bottom Menu

efpia-logo EU imi logo

This work has received support from the EU/EFPIA Innovative Medicines Initiative Joint Undertaking EPAD grant agreement nº 115736

This website uses cookies to improve your experience. Accept Read More
Privacy & Cookies Policy

Privacy Overview

This website uses cookies to improve your experience while you navigate through the website. Out of these, the cookies that are categorized as necessary are stored on your browser as they are essential for the working of basic functionalities of the website. We also use third-party cookies that help us analyze and understand how you use this website. These cookies will be stored in your browser only with your consent. You also have the option to opt-out of these cookies. But opting out of some of these cookies may affect your browsing experience.
Necessary
Always Enabled
Necessary cookies are absolutely essential for the website to function properly. This category only includes cookies that ensures basic functionalities and security features of the website. These cookies do not store any personal information.
Non-necessary
Any cookies that may not be particularly necessary for the website to function and is used specifically to collect user personal data via analytics, ads, other embedded contents are termed as non-necessary cookies. It is mandatory to procure user consent prior to running these cookies on your website.
SAVE & ACCEPT